Catalyst Pharmaceuticals Stock Gets Relative Strength Rating Lift

The Relative Strength (RS) Rating for Catalyst Pharmaceuticals (CPRX) stock headed into a new percentile Monday, as it got a lift from 61 to 73.   Can You Really Time The Stock Market? IBD’s proprietary RS Rating identifies market leadership by using a 1 (worst) to 99 (best) score that shows how a stock’s price performance over the last 52…